Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Unternehmens-codeNVS
Name des UnternehmensNovartis AG
IPO-datumMay 07, 2001
Gegründet am1996
CEODr. Vasant (Vas) Narasimhan, M.D.
Anzahl der mitarbeiter75883
WertpapierartOrdinary Share
GeschäftsjahresendeMay 07
AddresseLichtstrasse 35
StadtBASEL
BörseJohannesburg Stock Exchange
LandSwitzerland
Postleitzahl4056
Telefon41613241111
Websitehttps://www.novartis.com/
Unternehmens-codeNVS
IPO-datumMay 07, 2001
Gegründet am1996
In den vergangenen 5 Jahren wurden insgesamt
36.74B
USD an Dividenden ausgeschüttet.
NVS.NB Approximate final Cash Dividend of gross USD 3.869541 going ex on Mar 12, 2025
NVS.NB Final Cash Dividend of gross USD 3.739544 paid on Apr 19, 2024 going ex on Mar 07, 2024
NVS.NB Final Cash Dividend of gross USD 3.498699 paid on Mar 20, 2023 going ex on Mar 09, 2023
NVS.NB Final Cash Dividend of gross USD 3.32525 paid on Mar 17, 2022 going ex on Mar 08, 2022
NVS.NB Final Cash Dividend of gross USD 3.199072 paid on Mar 15, 2021 going ex on Mar 04, 2021
NVS.NB Final Cash Dividend of gross USD 3.087366 paid on Mar 12, 2020 going ex on Mar 03, 2020